Sort
21,281 grants matching “influenza”
Alveolar responses to viral lung infection
$553,834Jaime Lynn Hook · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · HL
Advancing immune organoid technology and organoid combinations
$553,826Mark M Davis · Stanford University · U19 · FY2024 · AI
Scaling and Sustaining COVID-19 Vaccination through Meaningful Community Engagement and Care Coordination for Underserved Communities
$553,710Nicole A Stadnick · University Of California, San Diego · R01 · FY2025 · MD
DETERMINANTS OF H. INFLUENZAE VIRULENCE IN OTITIS MEDIA
$553,641Research Inst Nationwide Children'S Hosp · R01 · FY2002 · DC
B-1 cells, IgM and Protective Humoral Immunity to Influenza
$553,449Nicole Baumgarth · University Of California At Davis · R01 · FY2021 · AI
Optimizing a Universal Influenza Subunit Nano/Microparticulate Vaccine
$553,436Kristy M Ainslie · Univ Of North Carolina Chapel Hill · R01 · FY2024 · AI
HIV infection and innate defense mechanisms in dendritic cells
$553,417Ana Fernandez-Sesma · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2014 · AI
Molecular simulations of lipid curvature stress and its effect on transmembrane proteins
$553,315Alexander Sodt · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2016 · HD
Risk of Influenza Infection In A Vaccinated Obese Population
$553,270Melinda A. Beck · Univ Of North Carolina Chapel Hill · R01 · FY2015 · AI
Synthetic Viral Genome Design for Rapid Vaccine Development
$553,207Eckard Wimmer · State University New York Stony Brook · R01 · FY2011 · AI
Novel Influenza A Nanovaccines for Broad Cross Protection
$553,128Baozhong Wang · Emory University · R01 · FY2012 · AI
Use of Clinical Samples to Identify Influenza Virus Antigenic Variants
$553,124Xiufeng Henry Wan · University Of Missouri-Columbia · R01 · FY2024 · AI
Use of Clinical Samples to Identify Influenza Virus Antigenic Variants
$553,124Xiufeng Henry Wan · University Of Missouri-Columbia · R01 · FY2023 · AI
Use of Clinical Samples to Identify Influenza Virus Antigenic Variants
$553,124Xiufeng Henry Wan · University Of Missouri-Columbia · R01 · FY2021 · AI
Use of Clinical Samples to Identify Influenza Virus Antigenic Variants
$553,124Xiufeng Henry Wan · University Of Missouri-Columbia · R01 · FY2020 · AI
Generation of antigen-specific regulation T cells
$553,106Harald Von Boehmer · Dana-Farber Cancer Inst · R37 · FY2007 · AI
Task A15: Mouse Models for Evaluation of Influenza Vaccines and Adjuvants
$552,993Norman Kneteman · Utah State University · N01 · FY2013 · AI
Synthetic Viral Genome Design for Rapid Vaccine Development
$552,986Eckard Wimmer · State University New York Stony Brook · R01 · FY2012 · AI
Modeling Health System Infectious Disease Data
$552,778Richard Platt · Harvard Pilgrim Health Care, Inc. · U01 · FY2008 · GM
Skeletal Muscle Loss and Dysfunction
$552,671Nathan K Lebrasseur · Mayo Clinic Rochester · P01 · FY2020 · AG
Vaccination strategies to overcome immune deficiencies in neonates
$552,662Martha A. Alexander-Miller · Wake Forest University Health Sciences · R01 · FY2013 · AI
Innate-like BCR activity as a template for universal vaccination against influenza virus
$552,569Daniel Lingwood · Massachusetts General Hospital · R01 · FY2018 · AI
FcRn-Targeted Mucosal Vaccination Against Influenza Infections
$552,555Xiaoping Zhu · Univ Of Maryland, College Park · R01 · FY2021 · AI
M2 peptide based vaccines against influenza
$552,548Washington University · U01 · FY2005 · AI
Role of Diabetes in MERS Coronavirus Pathogenesis
$552,435Matthew Bryan Frieman · University Of Maryland Baltimore · R01 · FY2022 · AI